NCD Program Database
The Cancer Alliance, formed by a group of established organizations and government agencies, aims to improve early diagnosis, affordability, quality, and impact of cancer care while enhancing legislation and the public policy environment for patients in sub-Saharan Africa (SSA). The Alliance involves a broad coalition of local partners from the public, private, and voluntary sectors, and strives to coordinate all individual cancer care efforts in the region to ensure effective and holistic cancer management through improved inter-organization cooperation. The Cancer Alliance is endorsed by the Kenyan National Minister of Health and the National Cancer Institute (NCI) of Kenya.
As a founding partner of the Alliance, Takeda has helped shape public policy, including through the drafting of the National Cancer Control Strategy in Kenya (2017-2021) with the Kenyan Ministry of Health, and contributed funding, resources and oncology expertise to the program to improve the monitoring of cancer incidences and type.
In line with the Alliance’s defined objectives, Takeda is working with partners to increase disease awareness and education amongst patients and healthcare practitioners; enhance and advance diagnosis and treatment of all cancers; promote sustainable development of medical support and facilities; and improve access to healthcare infrastructures and cancer medication in SSA on a not-for-profit basis.
We are also helping to train healthcare professionals in cancer care to increase the number of oncology specialists. In addition, the Alliance is developing a patient data collection and management system to advance tracking of cancer incidence and type, and inform policy-making. Another focus is developing initiatives, based on a patient’s ability to pay, that improve the affordability of high-quality medicines and of medical procedures. Lastly, the Alliance are working with national and local governments to enhance legislation and cancer public policy.
The Cancer Alliance aims to develop Nairobi, Kenya into a centre of excellence for cancer management in the sub-Saharan Africa region. Activities are initiated in Kenya and then expanded to East Africa (Rwanda, Tanzania, Uganda, Ethiopia, Mozambique) followed by West Africa (Nigeria, Ghana, Senegal, Angola).